Methyl Seq Kits

Agilent- SureSelect Human All Exon KitsAgilent SureSelectXT Human Methyl-Seq is the first comprehensive target enrichment system to enable researchers to focus on the regions where methylation is known to impact gene regulation.

It targets the most complete Methyl-Seq content, including cancer tissue-specific DMRs, GENCODE promoters, CpG islands, shores and shelves ±4kb, DNaseI hypersensitive sites and RefGenes.


Agilent Technologies

Home | About Us | Medical Division | Life Science Division | Our Partners | Careers | Newsroom | Legal Notice

All Rights reserved, Neopharm Group, Israel | Design by: VAZA | Developed by: The Shark Lady